Tecogen (TGEN) director Ahmed Ghoniem receives 25,000 stock options at $5.1700
Rhea-AI Filing Summary
TECOGEN INC. director Ahmed Ghoniem received a grant of stock options giving the right to buy 25,000 shares of common stock. The options have an exercise price of $5.1700 per share and vest 25% per year. Following this grant, he holds 25,000 derivative securities directly, with these options exercisable beginning on June 26, 2027 and expiring on June 26, 2036.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Ghoniem Ahmed
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 25,000 | $5.17 | $129K |
Holdings After Transaction:
Stock Option (Right to Buy) — 25,000 shares (Direct)
Footnotes (1)
- F1. Vests 25% per year
Key Figures
Options granted: 25,000 options
Exercise price: $5.1700 per share
Underlying shares: 25,000 shares
+4 more
7 metrics
Options granted
25,000 options
Grant of stock options reported on June 26, 2026
Exercise price
$5.1700 per share
Stock option exercise price
Underlying shares
25,000 shares
Common stock underlying the options
Post-grant derivative holdings
25,000 options
Total derivative securities following transaction
Vesting schedule
25% per year
Option vesting rate from footnote
Exercise start date
June 26, 2027
Date options first exercisable
Expiration date
June 26, 2036
Option expiration
Key Terms
Stock Option (Right to Buy), Grant, award, or other acquisition, derivative securities, vests 25% per year
4 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
Grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
derivative securities financial
"derivativeTransactionCount: 1 derivative-type records"
Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.
vests 25% per year financial
"Footnote states: "Vests 25% per year""
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did TECOGEN INC. (TGEN) director Ahmed Ghoniem report on this Form 4?
Ahmed Ghoniem reported receiving a grant of stock options for 25,000 shares of TECOGEN INC. common stock. These options are a compensation-related award, not an open-market stock purchase or sale, and are reflected as a derivative security position.
How many TECOGEN INC. (TGEN) stock options were granted to Ahmed Ghoniem?
The filing shows a grant of 25,000 stock options, each linked to one share of common stock. This entire 25,000-option position is reported as held directly after the transaction, representing his current derivative holdings noted in this Form 4.
What is the exercise price of Ahmed Ghoniem’s TECOGEN (TGEN) stock options?
The stock options have an exercise price of $5.1700 per share. This means Ghoniem may buy TECOGEN INC. common stock at $5.1700 per share once the options have vested and are exercisable, subject to the option terms.
When do Ahmed Ghoniem’s TECOGEN INC. (TGEN) options vest and expire?
The options vest 25% per year, according to the footnote. They become exercisable starting on June 26, 2027 and will expire on June 26, 2036, providing a long-term window during which they can be exercised once vested.
Does this TECOGEN INC. (TGEN) Form 4 show any open-market stock purchases or sales?
The report shows only a grant of stock options classified as a derivative security acquisition with code "A". The transaction_summary lists no open-market buys or sells, indicating this filing covers compensation-related option grants rather than market trading.